Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 9, 2013European Journal of CancerOpen Access

Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial

View Full Paper
Ask AI
Bookmark
Share

Authors

JTJone TrovikHaukeland University HospitalEWElisabeth WikHaukeland University HospitalHWHenrica M.J. WernerMaastricht University Medical Centre

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Trovik et al. (2013) studied this question.

synapsesocial.com/papers/6a73335ed98d9ee37dc8f537https://doi.org/10.1016/j.ejca.2013.06.016
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Trastuzumab‐based neoadjuvant therapy in patients with HER2‐positive breast cancer2010 · 111 citations
  2. 2The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies2007 · 22,449 citations
  3. 3Locoregional Relapse and Distant Metastasis in Conservatively Managed Triple Negative Early-Stage Breast Cancer2006 · 1,122 citations